Assessing Consistency in a Network Meta-Analysis to Compare Once Weekly Dulaglutide Versus Other Glp-1 Receptor Agonists in Patients with Type 2 Diabetes

Value Health. 2014 Nov;17(7):A335. doi: 10.1016/j.jval.2014.08.641. Epub 2014 Oct 26.

Authors

N Hawkins¹, A Padhiar¹, J Thompson¹, D A Scott¹, J N Eaton¹, N Varol², K Norrbacka², K S Boye³, C Nicolay⁴

Affiliations

¹ ICON Clinical Research UK Ltd., Oxford, UK.
² Eli Lilly and Company, Windlesham, UK.
³ Eli Lilly and Company, Indianapolis, IN, USA.
⁴ Eli Lilly and Company, Bad Homburg, Germany.

PMID: 27200592
DOI: 10.1016/j.jval.2014.08.641

No abstract available